-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Upgrades AVITA Medical to Buy, Announces $7 Price Target

Benzinga·08/07/2026 10:12:53
Listen to the news
BTIG analyst Ryan Zimmerman upgrades AVITA Medical (NASDAQ:RCEL) from Neutral to Buy and announces $7 price target.